Travecta Therapeutics

OverviewSuggest Edit

Travecta Therapeutics is a biotechnology company. It develops a platform to identify, simplify, and categorize small molecules for facilitating their transport across the blood-brain barrier, enabling physicians to treat diseases of the central nervous system and the eye.
TypePrivate
Founded2017
HQNew York, NY, US
Websitetravectatherapeutics.com

Latest Updates

Employees (est.) (Jul 2021)8
Cybersecurity ratingAMore

Key People/Management at Travecta Therapeutics

Mahmood Ahmed

Mahmood Ahmed

Chief Scientific Officer & Founder
Frankie Mak

Frankie Mak

Head of Medicinal Chemistry
Thomas Fratacci

Thomas Fratacci

Chief Financial Officer
Show more

Travecta Therapeutics Office Locations

Travecta Therapeutics has offices in New York and Singapore
New York, NY, US (HQ)
545 W 25th St 20th fl
Singapore, SG
79 Science Park Dr, 06
Show all (2)

Travecta Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2017

Travecta Therapeutics total Funding

$15 m

Travecta Therapeutics latest funding size

$15 m

Time since last funding

a year ago

Travecta Therapeutics investors

Travecta Therapeutics's latest funding round in May 2020 was reported to be $15 m. In total, Travecta Therapeutics has raised $15 m
Show all financial metrics

Travecta Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

90/100

SecurityScorecard logo

Travecta Therapeutics Online and Social Media Presence

Embed Graph

Travecta Therapeutics News and Updates

Singapore’s Travecta Therapeutics secures $15m in Series A funding

The proceeds will be used to support Travecta's development of its non-opioid product targeting pain. The post Singapore’s Travecta Therapeutics secures $15m in Series A funding appeared first on DealStreetAsia.

Travecta Therapeutics Raises $15M in Financing

Travecta Therapeutics, a NYC and Singapore-based biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain-barrier, secured US$15m in Series A funding.

Travecta Therapeutics Frequently Asked Questions

  • When was Travecta Therapeutics founded?

    Travecta Therapeutics was founded in 2017.

  • Who are Travecta Therapeutics key executives?

    Travecta Therapeutics's key executives are Mahmood Ahmed, Frankie Mak and Thomas Fratacci.

  • How many employees does Travecta Therapeutics have?

    Travecta Therapeutics has 8 employees.

  • Who are Travecta Therapeutics competitors?

    Competitors of Travecta Therapeutics include MetaboGen AB, TCR2 Therapeutics and VBI Vaccines.

  • Where is Travecta Therapeutics headquarters?

    Travecta Therapeutics headquarters is located at 545 W 25th St 20th fl, New York.

  • Where are Travecta Therapeutics offices?

    Travecta Therapeutics has offices in New York and Singapore.

  • How many offices does Travecta Therapeutics have?

    Travecta Therapeutics has 2 offices.